Aquatic Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.61M	Buy	+79,199	New	+$3.65M	0.13%	204
2025 Q2	–	Sell	-10,511	Closed	-$353K	–	1595
2025 Q1	$353K	Buy	10,511 +2,251	+27%	+$85.5K	0.01%	824
2024 Q4	$324K	Buy	+8,260	New	+$342K	0.01%	828
2024 Q3	–	Sell	-4,200	Closed	-$164K	–	1594
2024 Q2	$164K	Sell	4,200 -20,500	-83%	-$819K	0.01%	801
2024 Q1	$1.06M	Buy	24,700 +5,200	+27%	+$239K	0.03%	376
2023 Q4	$898K	Buy	19,500 +4,200	+27%	+$148K	0.02%	499
2023 Q3	$523K	Buy	+15,300	New	+$572K	0.02%	472
2023 Q2	–	Sell	-2,000	Closed	-$72K	–	1792
2023 Q1	$72K	Buy	+2,000	New	+$73.9K	﹤0.01%	817
2022 Q2	–	Sell	-400	Closed	-$12K	–	1614
2022 Q1	$12K	Sell	400 -5,000	-93%	-$150K	0.02%	627
2021 Q4	$169K	Buy	+5,400	New	+$161K	0.33%	52